PMS34 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS RALOXIFENE FOR TREATING OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN IN THE UNITED STATES
2011 ◽
Vol 14
(3)
◽
pp. A129
◽
A.C. Beaubrun
◽
J.B. Daugherty
2021 ◽
Vol 24
◽
pp. S240-S241
2019 ◽
Vol 45
(7)
◽
pp. 927-938
◽
Gary C. Brown
◽
Melissa M. Brown
◽
Brandon G. Busbee
A.S. Cha
◽
M. Zimmermann
◽
R. Hansen
2015 ◽
Vol 18
(3)
◽
pp. A298-A299
D. Shah
◽
V.R. Anupindi
◽
V. Vaidya
2016 ◽
Vol 19
(3)
◽
pp. A49
RL Harrington
◽
PM Zueger
◽
VM Kumar
◽
G Rigoni
◽
AM Atwood
◽
...
2010 ◽
Vol 95
(4)
◽
pp. 1672-1680
◽
Tracy S. Wang
◽
Kevin Cheung
◽
Pritesh Mehta
◽
Sanziana A. Roman
◽
Hugh D. Walker
◽
...
2017 ◽
Vol 152
(5)
◽
pp. S35-S36
Monica Saumoy
◽
Shailja Shah
◽
Yecheskel Schneider
◽
Nicole T. Shen
◽
Shawn Shah
◽
...
2018 ◽
Vol 21
◽
pp. S153-S154
Ava Yap
◽
Thomas A. Hope
◽
Claire E. Graves
◽
Wouter Kluijfhout
◽
Wen T. Shen
◽
...
2016 ◽
Vol 19
(3)
◽
pp. A219
V.M. Kumar
◽
R.N. Caskey
◽
D.R. Touchette